Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.


Interferon alfa-2a Product Approval Information - Licensing Action 9/10/03

Proper name: Interferon alfa-2a
Manufacturer: Hoffman-La Roche, Inc.
Indication for Use: Removal of Kaposi's sarcoma indication.
Approval Date: 9/10/2003
Type of submission: Biologics license application


Approval Letter - (PDF)

Page Last Updated: 09/30/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English